Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure

Cardiac contractility modulation (CCM) signals are non?excitatory signals applied during the absolute refractory period that have been shown to enhance the strength of left ventricular contraction without increasing myocardial oxygen consumption in studies carried out in animals and humans with hear...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Borggrefe, Martin (VerfasserIn) , Burkhoff, Daniel (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2012
In: European journal of heart failure
Year: 2012, Jahrgang: 14, Heft: 7, Pages: 703-712
ISSN:1879-0844
DOI:10.1093/eurjhf/hfs078
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1093/eurjhf/hfs078
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1093/eurjhf/hfs078
Volltext
Verfasserangaben:Martin Borggrefe and Daniel Burkhoff

MARC

LEADER 00000caa a2200000 c 4500
001 1572071664
003 DE-627
005 20230426124244.0
007 cr uuu---uuuuu
008 180417s2012 xx |||||o 00| ||eng c
024 7 |a 10.1093/eurjhf/hfs078  |2 doi 
035 |a (DE-627)1572071664 
035 |a (DE-576)502071664 
035 |a (DE-599)BSZ502071664 
035 |a (OCoLC)1341006550 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Borggrefe, Martin  |e VerfasserIn  |0 (DE-588)1025920546  |0 (DE-627)725574232  |0 (DE-576)370913426  |4 aut 
245 1 0 |a Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure  |c Martin Borggrefe and Daniel Burkhoff 
264 1 |c 2012 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First published: 18 February 2014 
500 |a Gesehen am 17.04.2018 
520 |a Cardiac contractility modulation (CCM) signals are non?excitatory signals applied during the absolute refractory period that have been shown to enhance the strength of left ventricular contraction without increasing myocardial oxygen consumption in studies carried out in animals and humans with heart failure and reduced ejection fraction. Studies from myocardial tissue of animals and humans with heart failure suggest that the mechanisms of these effects is that CCM drives expression of many genes that are abnormally expressed in heart failure towards normal, including proteins involved with calcium cycling and the myocardial contractile machinery. Clinical studies have primarily focused on patients with normal QRS durations in view of the fact that cardiac resynchronization (CRT) is a viable option for patients with prolonged QRS duration. These studies show that CCM improves exercise tolerance as indexed by peak oxygen consumption (VO2) and quality of life indexed by the Minnesota Living with Heart Failure Questionnaire. The device is currently available for clinical use in countries recognizing the CE mark and is undergoing additional testing in the USA under a protocol approved by the Federal Drug Administration. 
650 4 |a cardiac contractility modulation 
650 4 |a electrical treatment of heart failure 
650 4 |a heart failure 
700 1 |a Burkhoff, Daniel  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t European journal of heart failure  |d Oxford : Wiley, 1999  |g 14(2012), 7, Seite 703-712  |h Online-Ressource  |w (DE-627)306658291  |w (DE-600)1500332-2  |w (DE-576)081985983  |x 1879-0844  |7 nnas  |a Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure 
773 1 8 |g volume:14  |g year:2012  |g number:7  |g pages:703-712  |g extent:10  |a Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure 
856 4 0 |u http://dx.doi.org/10.1093/eurjhf/hfs078  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1093/eurjhf/hfs078  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180417 
993 |a Article 
994 |a 2012 
998 |g 1025920546  |a Borggrefe, Martin  |m 1025920546:Borggrefe, Martin  |d 60000  |d 61000  |e 60000PB1025920546  |e 61000PB1025920546  |k 0/60000/  |k 1/60000/61000/  |p 1  |x j 
999 |a KXP-PPN1572071664  |e 3006224329 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1572071664","physDesc":[{"extent":"10 S."}],"title":[{"title_sort":"Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure","title":"Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure"}],"note":["First published: 18 February 2014","Gesehen am 17.04.2018"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"display":"Borggrefe, Martin","role":"aut","given":"Martin","family":"Borggrefe"},{"given":"Daniel","role":"aut","family":"Burkhoff","display":"Burkhoff, Daniel"}],"relHost":[{"titleAlt":[{"title":"EJHF"}],"pubHistory":["1.1999 -"],"id":{"doi":["10.1002/(ISSN)1879-0844"],"zdb":["1500332-2"],"issn":["1879-0844"],"eki":["306658291"]},"part":{"year":"2012","volume":"14","pages":"703-712","extent":"10","text":"14(2012), 7, Seite 703-712","issue":"7"},"origin":[{"publisher":"Oxford University Press ; Elsevier Science ; Oxford Univ. Press ; Wiley","dateIssuedDisp":"1999-","dateIssuedKey":"1999","publisherPlace":"Oxford ; Amsterdam [u.a.] ; Oxford [u.a.] ; Oxford"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 07.01.25"],"title":[{"title":"European journal of heart failure","title_sort":"European journal of heart failure","subtitle":"journal of the Working Group on Heart Failure of the European Society of Cardiology"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"306658291","disp":"Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failureEuropean journal of heart failure"}],"origin":[{"dateIssuedDisp":"2012","dateIssuedKey":"2012"}],"id":{"eki":["1572071664"],"doi":["10.1093/eurjhf/hfs078"]},"name":{"displayForm":["Martin Borggrefe and Daniel Burkhoff"]}} 
SRT |a BORGGREFEMCLINICALEF2012